Bad Homburg, Germany

Lena Schreiber


 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lena Schreiber - Innovator in Medical Device Technology

Introduction

Lena Schreiber is a prominent inventor based in Bad Homburg, Germany. She has made significant contributions to the field of medical devices, particularly in the area of blood treatment technology. With a total of 2 patents to her name, Lena's work is recognized for its innovative approach to enhancing medical equipment functionality.

Latest Patents

Lena's latest patents include a "Test device for testing functions of a pump" and a "Medical device and method of communication for a medical device." The first patent describes a test device designed to be inserted into the syringe receptacle of a pump, specifically for blood treatment apparatuses. This device is intended to test at least one function of the pump and includes a holding device for secure attachment to the apparatus. The second patent focuses on a medical device that features an output unit for system sounds, facilitating communication with users and other apparatuses.

Career Highlights

Lena Schreiber is currently employed at Fresenius Medical Care Deutschland GmbH, a leading company in the field of medical devices. Her role involves developing innovative solutions that improve patient care and treatment efficiency. Lena's expertise and dedication to her work have positioned her as a key player in her field.

Collaborations

Lena has collaborated with notable colleagues, including Alexander Schrörs and Robert Schröder. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Lena Schreiber's contributions to medical device innovation exemplify her commitment to improving healthcare technology. Her patents reflect a deep understanding of the needs within the medical field, and her work continues to influence advancements in blood treatment devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…